Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

De-Risking Investments in Medical Technology Innovation: Strengthening Decision-Making and Valuation Accuracy in Medical Startups

by Luigi Negri
Save 35% Save 35%
Current price ₹8,807.00
Original price ₹13,548.00
Original price ₹13,548.00
Original price ₹13,548.00
(-35%)
₹8,807.00
Current price ₹8,807.00

Imported Edition - Ships in 12-14 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9783032150066
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Publication Date:
  • Pages: 331
  • Original Price: EUR 119.89
  • Language: English
  • Edition: N/A
  • Item Weight: 563 grams
  • BISAC Subject(s): Industries / Healthcare

This book provides medical technology entrepreneurs and their investors with a decision-making methodology based on the scientific approach that maximizes their chances of success. It enriches the understanding of valuation for medical startups, proposing an approach that moves the focus from the sophistication of the forecasting and financial methodologies to the quantitative importance of high-quality business assumptions and the economic impact of each critical business decision. It also provides a complete set of visual, organized, and compelling mental maps tailored to the business of medical technology innovation; maps that visualize and link the medical venture’s decision-making and prediction problems. Their use minimizes the probability of overlooking critical decision problems on the path to successful execution while connecting them through a sequential and hierarchical framework. Finally, the book provides practical, real-life examples of how the scientific approach to decision-making can be used in medical technology startups outside the clinical trial area. The reader is left with various sets of valuable and practical tools that can be individually applied.

Dr Luigi Negri is Founder and CEO for ThinKeen(R) Global Consulting (Miami, FL, USA) and Venture Partner of Obloo(R) Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups. In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions. These positions included VP of Northern & Central Europe for Becton Dickinson(R) (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care(R).

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us